InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,447.87
(
-0.31%
)
US TECH 100
19,051.60
(
0.49%
)
Dow Jones
39,411.21
(
0.67%
)
Brent Oil
84.84
(
-0.50%
)
Bitcoin
61,238.52
(
1.62%
)
Post# of 6939
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Ned Serious

Send PM Follow Ignore
Followers 15
Posts 1189
Boards Moderated 1
Alias Born 12/31/2008

Ned Serious

Re: None

Wednesday, 04/30/2014 11:29:14 PM

Wednesday, April 30, 2014 11:29:14 PM

Post# of 6939
ACHN - Two PR's in one today. From an investor standpoint, I'd rather have the company PR one, then wait a few days and PR the other. I wonder if company's ever think of that? Are they obligated to PR within a certain timeframe???

Dosing Initiated in Phase 1 Study to Evaluate the Safety, Tolerability and Antiviral Activity of ACH-3422, NS5B Uridine-Analog Nucleotide Prodrug -

- Initiated Phase 2 Study Evaluating ACH-3102, Second-Generation NS5A Inhibitor, With Sofosbuvir for 8 Weeks of Treatment or Less in Genotype 1 HCV Treatment-Naïve Patients -

These thoughts are just mine, not right, not wrong, just thoughts. Invest in what you believe in, not what I believe in. Do your research, and invest in the facts.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up